Literature DB >> 27599405

Certolizumab pegol, a pegylated anti-TNF-α antagonist, caused de novo-onset palmoplantar pustulosis followed by generalized pustular psoriasis in a patient with rheumatoid arthritis.

Haruka Koizumi1, Atsushi Tokuriki1, Noritaka Oyama1, Hideki Ido1, Kazumitsu Sugiura2, Masashi Akiyama2, Minoru Hasegawa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27599405     DOI： 10.1111/1346-8138.13530

Source DB:  PubMed          Journal:  J Dermatol        ISSN： 0385-2407            Impact factor:   4.005


× No keyword cloud information.
  4 in total

Review 1.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

2.  TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management.

Authors:  Sara Jiayang Li; Lourdes M Perez-Chada; Joseph F Merola
Journal:  J Psoriasis Psoriatic Arthritis       Date:  2018-11-21

3.  Paradoxical Skin Reaction to Certolizumab, an Overlap of Pyoderma Gangrenosum and Psoriasis in a Young Woman Treated for Ankylosing Spondylitis: Case Report with Literature Review.

Authors:  Anna Gawdzik; Małgorzata Ponikowska; Alina Jankowska-Konsur; Zdzisław Woźniak; Joanna Maj; Jacek C Szepietowski
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-23

4.  Genetic polymorphism of IL36RN in Han patients with generalized pustular psoriasis in Sichuan region of China: A case-control study.

Authors:  Zhongtao Li; Qianyi Yang; Sheng Wang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.